Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.

James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, Torp-Pedersen C, Sharma AM, Shepherd GM, Rode RA, Renz CL; SCOUT Investigators.

N Engl J Med. 2010 Sep 2;363(10):905-17. doi: 10.1056/NEJMoa1003114.

2.

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial.

Konstam MA, Neaton JD, Dickstein K, Drexler H, Komajda M, Martinez FA, Riegger GA, Malbecq W, Smith RD, Guptha S, Poole-Wilson PA; HEAAL Investigators.

Lancet. 2009 Nov 28;374(9704):1840-8. doi: 10.1016/S0140-6736(09)61913-9. Epub 2009 Nov 16. Erratum in: Lancet. 2009 Dec 5;374(9705):1888.

PMID:
19922995
3.

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R; SEAS Investigators.

N Engl J Med. 2008 Sep 25;359(13):1343-56. doi: 10.1056/NEJMoa0804602. Epub 2008 Sep 2.

4.

Deficiency of antibody formation to HBsAg in the pathogenesis of chronic hepatitis and cirrhosis?

Schlicht I, Gadow J, Ortmans H, Jorno L, Gentz HD, Wolter G, Hoppe I.

Acta Hepatogastroenterol (Stuttg). 1979 Dec;26(6):450-6.

PMID:
549426
5.

[HBsAg and anti-HBs in liver diseases, blood donors and hospital personnel].

Schlicht I, Gadow J, Wolter G, Ortmans H, Jorno L, Gentz D.

Verh Dtsch Ges Inn Med. 1977 Apr 17-21;83:568-72. German. No abstract available.

PMID:
612034

Supplemental Content

Loading ...
Support Center